Sales of pharmaceutical products in the world's 10 leading marketsincreased 6% during the first four months of 1997 to a total of $54.5 billion, according to new data published by IMS International.
Fastest market growth during the period was reported for North America, with sales in the USA and Canada rising 11% and 10% respectively.
The seven leading European markets showed combined growth of 4%, up from 3% during the first quarter, with the greatest advance reported for Spain, with turnover rising 9%, according to IMS. Sales in Italy and the UK increased 6% in the period, while France advanced 5%. Growth in Germany was flat, after the decline of 1% reported for the first quarter of the year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze